Association of alleles at polymorphic sites in the Osteopontin encoding gene in young type 1 diabetic patients.

[1]  Y. S. Kim,et al.  Osteopontin Promotes the Development of Natural Killer Cells from Hematopoietic Stem Cells , 2008, Stem cells.

[2]  M. Shinohara,et al.  Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. , 2008, Immunity.

[3]  M. Trucco,et al.  To be DR8 or not to be DQ8, that is the question , 2007, Pediatric diabetes.

[4]  D. Barad,et al.  Gender as risk factor for autoimmune diseases. , 2007, Journal of autoimmunity.

[5]  N. Bottini,et al.  Role of PTPN22 in type 1 diabetes and other autoimmune diseases. , 2006, Seminars in immunology.

[6]  Denis Daneman,et al.  Type 1 diabetes , 2018, The Lancet.

[7]  J. Todd,et al.  Bmc Medical Genetics Elevated White Cell Count in Acute Coronary Syndromes: Relationship to Variants in Inflammatory and Thrombotic Genes Inflammationacute Coronary Syndromeswhite Cell Countinterleukin 1 Receptor Antagonistinterleukin 6 , 2004 .

[8]  N. Serrano,et al.  Non-HLA associations with autoimmune diseases. , 2006, Autoimmunity reviews.

[9]  C. Gorodezky,et al.  HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example. , 2006, Autoimmunity reviews.

[10]  K. Badenhoop,et al.  Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. , 2005, European journal of endocrinology.

[11]  C. Polychronakos,et al.  Immunogenetics of Type 1 Diabetes , 2005, Hormone Research in Paediatrics.

[12]  A. R. Vancha,et al.  Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production. , 2005, The Journal of endocrinology.

[13]  R. Ravazzolo,et al.  A polymorphic variant inside the osteopontin gene shows association with disease course in oligoarticular juvenile idiopathic arthritis , 2005, Annals of the rheumatic diseases.

[14]  T. Ahrens,et al.  Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. , 2005, Blood.

[15]  R. Ravazzolo,et al.  Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[16]  R. Ravazzolo,et al.  Polymorphisms in the osteopontin promoter affect its transcriptional activity. , 2004, Physiological genomics.

[17]  R. Lorini,et al.  Diabetes incidence in 0- to 14-year age-group in Italy: a 10-year prospective study. , 2004, Diabetes care.

[18]  C. Aspord,et al.  Early events in islets and pancreatic lymph nodes in autoimmune diabetes. , 2004, Journal of autoimmunity.

[19]  A. Chiocchetti,et al.  High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. , 2003, Blood.

[20]  P. Bingley,et al.  The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence , 2003, Diabetologia.

[21]  J. Haines,et al.  Osteopontin polymorphisms and disease course in multiple sclerosis , 2003, Genes and Immunity.

[22]  R. Pedotti,et al.  Response to Comment on "The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease" , 2003, Science.

[23]  N. Fedarko,et al.  Six Genes Expressed in Bones and Teeth Encode the Current Members of the SIBLING Family of Proteins , 2003, Connective tissue research.

[24]  J. Ilonen,et al.  Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. , 2002, The Journal of clinical endocrinology and metabolism.

[25]  M. Noda,et al.  Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Ilonen,et al.  Genetic risk determines the emergence of diabetes-associated autoantibodies in young children. , 2002, Diabetes.

[27]  L. Klein,et al.  Cutting Edge: Attenuated Experimental Autoimmune Encephalomyelitis in Eta-1/Osteopontin-Deficient Mice1 , 2002, The Journal of Immunology.

[28]  E. Bonifacio,et al.  Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study. , 2001, Diabetes Care.

[29]  G. d’Annunzio,et al.  Antibodies to tissue transglutaminase C in newly diagnosed and long-standing Type I diabetes mellitus , 2000, Diabetologia.

[30]  M. Glimcher,et al.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. , 2000, Science.

[31]  P. A. Biro,et al.  Osteopontin is an autoantigen of the somatostatin cells in human islets: identification by screening random peptide libraries with sera of patients with insulin-dependent diabetes mellitus. , 1999, Vaccine.

[32]  M. Hatano,et al.  Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[33]  Amanda J. Wilson,et al.  A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients , 1998, Nature Genetics.

[34]  P. Højrup,et al.  Posttranslational modifications of bovine osteopontin: Identification of twenty‐eight phosphorylation and three O‐glycosylation sites , 1995, Protein science : a publication of the Protein Society.

[35]  D. Denhardt,et al.  Osteopontin: a protein with diverse functions , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  H. Cantor,et al.  Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. , 1991, Journal of immunology.

[37]  H. Cantor,et al.  Dysregulated expression of the T cell cytokine Eta-1 in CD4-8- lymphocytes during the development of murine autoimmune disease , 1990, The Journal of experimental medicine.

[38]  R. Ravazzolo,et al.  The first intron of the human osteopontin gene contains a C/EBP-beta-responsive enhancer. , 2003, Gene expression.

[39]  E. Gale,et al.  Diabetes and gender , 2001, Diabetologia.

[40]  M. Owen,et al.  Genotyping single nucleotide polymorphisms by primer extension and high performance liquid chromatography , 1999, Human Genetics.

[41]  G. d’Annunzio,et al.  IDDM and Autoimmune Thyroid Disease in the Pediatric Age Group , 1996, Journal of pediatric endocrinology & metabolism : JPEM.

[42]  G. d’Annunzio,et al.  Clinical Aspects of Coeliac Disease in Children with Insulin-Dependent Diabetes Mellitus , 1996, Journal of pediatric endocrinology & metabolism : JPEM.

[43]  N Risch,et al.  Assessing the role of HLA-linked and unlinked determinants of disease. , 1987, American journal of human genetics.